サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193299

坐薬用脂肪性基剤市場：基剤タイプ別（硬質脂肪、水混和性基剤、乳化性基剤）：世界の機会分析および産業予測、2021-2031年

Fatty Bases for Suppositories Market By Base Type (Hard Fat, Water Miscible Base, Emulsifying Bases): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 250 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
坐薬用脂肪性基剤市場：基剤タイプ別（硬質脂肪、水混和性基剤、乳化性基剤）：世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 250 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

坐薬用脂肪性基剤の世界市場は、2021年の1億9790万米ドルから2031年までに3億3950万米ドルを獲得し、2022年から2031年にかけてCAGRは5.59%と予想されています。

座薬は、口以外の体腔に挿入することを目的とした固形状の薬物です。膣道、直腸、尿道などに挿入することができます。挿入された後、腔内の液体で溶けるか、溶解して薬が放出されます。直腸座薬、膣座薬、尿道座薬があり、それぞれ挿入する場所が異なります。これらの薬も局所的に効果を発揮します。さらに、薬の代謝を止める初回通過作用がないです。苦い薬や不快な薬も、坐薬なら効果的に届けることができます。坐薬は小児医療において、便秘に関連する症状に対応するために頻繁に使用されています。

主に小児や老人の患者さんでは、ドラッグデリバリーにおいて脂肪系の賦形剤が大きな役割を果たします。小児や老人のドラッグデリバリーには、直腸ルートが大きな選択肢となります。予想される期間において、市場の成長は、いくつかの低分子量薬物の迅速な吸収やリンパ系吸収の可能性などの利点による脂肪ベースの座薬の需要増加によって支援されると予想されます。坐薬用脂肪性基剤は直腸および膣へのドラッグデリバリーに使用されてきた長い歴史がありますが、これらの製品の現在の世界市場は、主に直腸用製品の使用に対する消費者の受容と意欲の欠如によって制約を受けています。さらに、油脂性座薬の製造が困難であることも、市場拡大をやや抑制すると考えられています。

坐薬用脂肪性基剤市場は、先進国におけるヘルスケア支出の増加や人口の高齢化によって牽引されています。これらの人口では、直腸ルートは薬物送達に理想的な選択肢です。座薬の需要の高まりは、特定の低分子量医薬品の迅速な吸収やリンパ系への吸収の可能性などの利点から、予測期間中の市場拡大を支えるものと思われます。座薬の分野は、物理的・化学的安定性の向上、粘膜に対する中性化、ほぼすべての活性化合物との完全な適合性などの結果として、拡大すると予想されます。これは、世界の坐薬用脂肪性基剤市場の成長に貢献することが期待されます。

COVID-19パンデミック急増時に、自己投薬は、薬を服用するための一般的な慣行でした。多数の治療施設や単一の医師だけのクリニックは、パンデミックのために閉鎖しなければならず、一般市民はタイムリーな医療を奪われました。パンデミックは、セルフメディケーションを促進しました。セルフメディケーションの方法として、副腎皮質ホルモン外用薬が最も広く使用されました。最も広く使用された外用薬には、抗アクネ剤、コルチコステロイド、コンボ剤（コルチコステロイド、抗生物質、抗真菌剤）、保湿剤、坐薬が含まれていました。セルフメディケーションによる市販薬や外用薬の需要の高まりが、座薬の市場に利益をもたらしています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析
  • 規制ガイドライン
  • バリューチェーン分析
  • 市場シェア分析
  • 主要規制の分析
  • 特許情勢

第4章 坐薬用脂肪性基剤市場：塩基性タイプ別

  • 概要
    • 市場規模および予測
  • ハードファット
    • 主な市場動向、成長要因、機会
    • 市場規模及び予測：地域別
    • 市場分析：国別分析
  • 水混和性ベース
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 乳化性ベース
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第5章 坐薬用脂肪性基剤市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測：ベースタイプ別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：ベースタイプ別
    • 欧州市場規模・予測：国別
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他の欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：ベースタイプ別
    • アジア太平洋地域の市場規模・予測：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：ベースタイプ別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • サウジアラビア
      • UAE
      • 南アフリカ
      • LAMEAの残りの地域

第6章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第7章 企業プロファイル

  • IOI Oleo GmbH
  • SpecializedRx Products, LLC
  • CD Formulation
  • Dow
  • Croda International Plc
  • STEARINERIE DUBOIS
  • Gattefosse
  • Tianshui Huayuan Pharmaceutical Equipment technology Co.,ltd
図表

LIST OF TABLES

  • TABLE 1. GLOBAL FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 2. FATTY BASES FOR SUPPOSITORIES MARKET SIZE, FOR HARD FAT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. FATTY BASES FOR SUPPOSITORIES MARKET FOR HARD FAT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. FATTY BASES FOR SUPPOSITORIES MARKET SIZE, FOR WATER MISCIBLE BASE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. FATTY BASES FOR SUPPOSITORIES MARKET FOR WATER MISCIBLE BASE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. FATTY BASES FOR SUPPOSITORIES MARKET SIZE, FOR EMULSIFYING BASES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. FATTY BASES FOR SUPPOSITORIES MARKET FOR EMULSIFYING BASES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. FATTY BASES FOR SUPPOSITORIES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. NORTH AMERICA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 10. NORTH AMERICA FATTY BASES FOR SUPPOSITORIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. U.S. FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 12. CANADA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 13. MEXICO FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 14. EUROPE FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 15. EUROPE FATTY BASES FOR SUPPOSITORIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. GERMANY FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 17. UNITED KINGDOM FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 18. FRANCE FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 19. SPAIN FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 20. ITALY FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 21. REST OF EUROPE FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 22. ASIA-PACIFIC FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 23. ASIA-PACIFIC FATTY BASES FOR SUPPOSITORIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. CHINA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 25. JAPAN FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 26. INDIA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 27. SOUTH KOREA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 28. AUSTRALIA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 29. REST OF ASIA PACIFIC FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 30. LAMEA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 31. LAMEA FATTY BASES FOR SUPPOSITORIES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. BRAZIL FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 33. SAUDI ARABIA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 34. UAE FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 35. SOUTH AFRICA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 36. REST OF LAMEA FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE, 2021-2031 ($MILLION)
  • TABLE 37.IOI OLEO GMBH: COMPANY SNAPSHOT
  • TABLE 38.IOI OLEO GMBH: OPERATING SEGMENTS
  • TABLE 39.IOI OLEO GMBH: PRODUCT PORTFOLIO
  • TABLE 40.IOI OLEO GMBH: NET SALES,
  • TABLE 41.IOI OLEO GMBH: KEY STRATERGIES
  • TABLE 42.SPECIALIZEDRX PRODUCTS, LLC: COMPANY SNAPSHOT
  • TABLE 43.SPECIALIZEDRX PRODUCTS, LLC: OPERATING SEGMENTS
  • TABLE 44.SPECIALIZEDRX PRODUCTS, LLC: PRODUCT PORTFOLIO
  • TABLE 45.SPECIALIZEDRX PRODUCTS, LLC: NET SALES,
  • TABLE 46.SPECIALIZEDRX PRODUCTS, LLC: KEY STRATERGIES
  • TABLE 47.CD FORMULATION: COMPANY SNAPSHOT
  • TABLE 48.CD FORMULATION: OPERATING SEGMENTS
  • TABLE 49.CD FORMULATION: PRODUCT PORTFOLIO
  • TABLE 50.CD FORMULATION: NET SALES,
  • TABLE 51.CD FORMULATION: KEY STRATERGIES
  • TABLE 52.DOW: COMPANY SNAPSHOT
  • TABLE 53.DOW: OPERATING SEGMENTS
  • TABLE 54.DOW: PRODUCT PORTFOLIO
  • TABLE 55.DOW: NET SALES,
  • TABLE 56.DOW: KEY STRATERGIES
  • TABLE 57.CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
  • TABLE 58.CRODA INTERNATIONAL PLC: OPERATING SEGMENTS
  • TABLE 59.CRODA INTERNATIONAL PLC: PRODUCT PORTFOLIO
  • TABLE 60.CRODA INTERNATIONAL PLC: NET SALES,
  • TABLE 61.CRODA INTERNATIONAL PLC: KEY STRATERGIES
  • TABLE 62.STEARINERIE DUBOIS: COMPANY SNAPSHOT
  • TABLE 63.STEARINERIE DUBOIS: OPERATING SEGMENTS
  • TABLE 64.STEARINERIE DUBOIS: PRODUCT PORTFOLIO
  • TABLE 65.STEARINERIE DUBOIS: NET SALES,
  • TABLE 66.STEARINERIE DUBOIS: KEY STRATERGIES
  • TABLE 67.GATTEFOSSE: COMPANY SNAPSHOT
  • TABLE 68.GATTEFOSSE: OPERATING SEGMENTS
  • TABLE 69.GATTEFOSSE: PRODUCT PORTFOLIO
  • TABLE 70.GATTEFOSSE: NET SALES,
  • TABLE 71.GATTEFOSSE: KEY STRATERGIES
  • TABLE 72.TIANSHUI HUAYUAN PHARMACEUTICAL EQUIPMENT TECHNOLOGY CO.,LTD: COMPANY SNAPSHOT
  • TABLE 73.TIANSHUI HUAYUAN PHARMACEUTICAL EQUIPMENT TECHNOLOGY CO.,LTD: OPERATING SEGMENTS
  • TABLE 74.TIANSHUI HUAYUAN PHARMACEUTICAL EQUIPMENT TECHNOLOGY CO.,LTD: PRODUCT PORTFOLIO
  • TABLE 75.TIANSHUI HUAYUAN PHARMACEUTICAL EQUIPMENT TECHNOLOGY CO.,LTD: NET SALES,
  • TABLE 76.TIANSHUI HUAYUAN PHARMACEUTICAL EQUIPMENT TECHNOLOGY CO.,LTD: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.FATTY BASES FOR SUPPOSITORIES MARKET SEGMENTATION
  • FIGURE 2.FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031
  • FIGURE 3.FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.FATTY BASES FOR SUPPOSITORIES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.REGULATORY GUIDELINES
  • FIGURE 13.VALUE CHAIN ANALYSIS
  • FIGURE 14.MARKET SHARE ANALYSIS
  • FIGURE 15.KEY REGULATION ANALYSIS
  • FIGURE 16.PATENT ANALYSIS BY COMPANY
  • FIGURE 17.PATENT ANALYSIS BY COUNTRY
  • FIGURE 18.FATTY BASES FOR SUPPOSITORIES MARKET,BY BASE TYPE,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HARD FAT FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF WATER MISCIBLE BASE FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF EMULSIFYING BASES FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031(%)
  • FIGURE 22.FATTY BASES FOR SUPPOSITORIES MARKET BY REGION,2021
  • FIGURE 23.U.S. FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 24.CANADA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 25.MEXICO FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 26.GERMANY FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 27.UNITED KINGDOM FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 28.FRANCE FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 29.SPAIN FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 30.ITALY FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 31.REST OF EUROPE FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 32.CHINA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 33.JAPAN FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 34.INDIA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 35.SOUTH KOREA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 36.AUSTRALIA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 37.REST OF ASIA PACIFIC FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 38.BRAZIL FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 39.SAUDI ARABIA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 40.UAE FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 41.SOUTH AFRICA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 42.REST OF LAMEA FATTY BASES FOR SUPPOSITORIES MARKET,2021-2031($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47.COMPETITIVE DASHBOARD
  • FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 49.IOI OLEO GMBH.: NET SALES ,($MILLION)
  • FIGURE 50.SPECIALIZEDRX PRODUCTS, LLC.: NET SALES ,($MILLION)
  • FIGURE 51.CD FORMULATION.: NET SALES ,($MILLION)
  • FIGURE 52.DOW.: NET SALES ,($MILLION)
  • FIGURE 53.CRODA INTERNATIONAL PLC.: NET SALES ,($MILLION)
  • FIGURE 54.STEARINERIE DUBOIS.: NET SALES ,($MILLION)
  • FIGURE 55.GATTEFOSSE.: NET SALES ,($MILLION)
  • FIGURE 56.TIANSHUI HUAYUAN PHARMACEUTICAL EQUIPMENT TECHNOLOGY CO.,LTD.: NET SALES ,($MILLION)
目次
Product Code: A31722

The global fatty bases for suppositories market is envisioned to garner $339.5 million by 2031, growing from $197.9 million in 2021, at a CAGR of 5.59% from 2022 to 2031.

A suppository is a solid form of medication that is intended to be inserted into bodily cavities other than the mouth. They can be inserted in the vaginal canal, rectum, or urethra. After being inserted, the objects melt or dissolve in the fluids of the cavity, releasing the medicines. Rectal, vaginal, and urethral suppositories are available, each with a different insertion location. These medicines also have an effect locally. Additionally, there is no first-pass action, which stops the drug's metabolism. Drugs that are bitter or offensive can be delivered effectively using suppositories. Suppositories are frequently used in paediatric medicine to address constipation-related symptoms.

Primarily in pediatric and geriatric patients, the fat-based excipients play a significant role in drug delivery. For drug delivery among pediatric and geriatric populations, the rectal route is a great alternative. Over the anticipated period, the market growth is anticipated to be aided by the rising demand for fat-based suppositories due to their benefits, including the quick absorption of several low molecular weight drugs and the potential for lymphatic system absorption. Although fatty bases for suppositories have a long history of use in rectal and vaginal drug delivery, the current global market for these products is constrained primarily by a lack of consumer acceptance and willingness to use rectal products. Additionally, it is thought that the difficulties in producing oil-based suppositories will somewhat restrain the market expansion.

The fatty basses for suppositories market is being driven by rising healthcare expenditure in developed countries and an ageing population. In these populations, the rectal route is an ideal choice for medication delivery. Growing demand for suppositories is likely to support market expansion over the forecast period due to benefits such as quick absorption of certain low molecular weight pharmaceuticals and the possibility of absorption into the lymphatic system. The suppositories sector is expected to rise as a result of improved physical and chemical stability, neutrality toward mucosal membranes, and full compatibility with almost all active compounds. This helps to the global fatty bases for suppositories market growth. These factors are further expected to propel the global fatty bases suppositories market growth.

During the COVID-19 pandemic surge, self-medication was a common practice for taking medications. Numerous treatment facilities and clinics with just single doctor had to close due to the pandemic, depriving the general public of timely medical care. The pandemic has encouraged self-medication. Topical corticosteroids were the self-medication methods that were most widely used. The most widely used topical drugs included anti-acne drugs, corticosteroids, combos (corticosteroids, antibiotics, and antifungals), moisturizers, and suppositories. The rise in demand for over-the-counter and topical medications brought on by self-medication has benefited the market for suppositories.

The key players profiled in this report include Unither, Bliss GVS Pharma Ltd., Delpharm, ATRAL, Aenova Holding GmBH, FAMAR, LGV (Laboratories Mayoly Spindler), and Priyans Drugs.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the fatty bases for suppositories market analysis from 2021 to 2031 to identify the prevailing fatty bases for suppositories market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the fatty bases for suppositories market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global fatty bases for suppositories market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Base Type

  • Hard Fat
  • Water Miscible Base
  • Emulsifying Bases

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest Of Asia Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • IOI Oleo GmbH
    • SpecializedRx Products, LLC
    • CD Formulation
    • Dow
    • Croda International Plc
    • STEARINERIE DUBOIS
    • Gattefosse
    • Tianshui Huayuan Pharmaceutical Equipment technology Co.,ltd

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Regulatory Guidelines
  • 3.8.Value Chain Analysis
  • 3.9.Market Share Analysis
  • 3.10.Key Regulation Analysis
  • 3.11.Patent Landscape

CHAPTER 4: FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Hard Fat
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Water Miscible Base
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Emulsifying Bases
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: FATTY BASES FOR SUPPOSITORIES MARKET, BY REGION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 North America
    • 5.2.1 Key trends and opportunities
    • 5.2.2 North America Market size and forecast, by Base Type
    • 5.2.3 North America Market size and forecast, by country
      • 5.2.3.1 U.S.
      • 5.2.3.1.1 Market size and forecast, by Base Type
      • 5.2.3.2 Canada
      • 5.2.3.2.1 Market size and forecast, by Base Type
      • 5.2.3.3 Mexico
      • 5.2.3.3.1 Market size and forecast, by Base Type
  • 5.3 Europe
    • 5.3.1 Key trends and opportunities
    • 5.3.2 Europe Market size and forecast, by Base Type
    • 5.3.3 Europe Market size and forecast, by country
      • 5.3.3.1 Germany
      • 5.3.3.1.1 Market size and forecast, by Base Type
      • 5.3.3.2 United Kingdom
      • 5.3.3.2.1 Market size and forecast, by Base Type
      • 5.3.3.3 France
      • 5.3.3.3.1 Market size and forecast, by Base Type
      • 5.3.3.4 Spain
      • 5.3.3.4.1 Market size and forecast, by Base Type
      • 5.3.3.5 Italy
      • 5.3.3.5.1 Market size and forecast, by Base Type
      • 5.3.3.6 Rest of Europe
      • 5.3.3.6.1 Market size and forecast, by Base Type
  • 5.4 Asia-Pacific
    • 5.4.1 Key trends and opportunities
    • 5.4.2 Asia-Pacific Market size and forecast, by Base Type
    • 5.4.3 Asia-Pacific Market size and forecast, by country
      • 5.4.3.1 China
      • 5.4.3.1.1 Market size and forecast, by Base Type
      • 5.4.3.2 Japan
      • 5.4.3.2.1 Market size and forecast, by Base Type
      • 5.4.3.3 India
      • 5.4.3.3.1 Market size and forecast, by Base Type
      • 5.4.3.4 South Korea
      • 5.4.3.4.1 Market size and forecast, by Base Type
      • 5.4.3.5 Australia
      • 5.4.3.5.1 Market size and forecast, by Base Type
      • 5.4.3.6 Rest Of Asia Pacific
      • 5.4.3.6.1 Market size and forecast, by Base Type
  • 5.5 LAMEA
    • 5.5.1 Key trends and opportunities
    • 5.5.2 LAMEA Market size and forecast, by Base Type
    • 5.5.3 LAMEA Market size and forecast, by country
      • 5.5.3.1 Brazil
      • 5.5.3.1.1 Market size and forecast, by Base Type
      • 5.5.3.2 Saudi Arabia
      • 5.5.3.2.1 Market size and forecast, by Base Type
      • 5.5.3.3 UAE
      • 5.5.3.3.1 Market size and forecast, by Base Type
      • 5.5.3.4 South Africa
      • 5.5.3.4.1 Market size and forecast, by Base Type
      • 5.5.3.5 Rest of LAMEA
      • 5.5.3.5.1 Market size and forecast, by Base Type

CHAPTER 6: COMPANY LANDSCAPE

  • 6.1. Introduction
  • 6.2. Top winning strategies
  • 6.3. Product Mapping of Top 10 Player
  • 6.4. Competitive Dashboard
  • 6.5. Competitive Heatmap
  • 6.6. Key developments

CHAPTER 7: COMPANY PROFILES

  • 7.1 IOI Oleo GmbH
    • 7.1.1 Company overview
    • 7.1.2 Company snapshot
    • 7.1.3 Operating business segments
    • 7.1.4 Product portfolio
    • 7.1.5 Business performance
    • 7.1.6 Key strategic moves and developments
  • 7.2 SpecializedRx Products, LLC
    • 7.2.1 Company overview
    • 7.2.2 Company snapshot
    • 7.2.3 Operating business segments
    • 7.2.4 Product portfolio
    • 7.2.5 Business performance
    • 7.2.6 Key strategic moves and developments
  • 7.3 CD Formulation
    • 7.3.1 Company overview
    • 7.3.2 Company snapshot
    • 7.3.3 Operating business segments
    • 7.3.4 Product portfolio
    • 7.3.5 Business performance
    • 7.3.6 Key strategic moves and developments
  • 7.4 Dow
    • 7.4.1 Company overview
    • 7.4.2 Company snapshot
    • 7.4.3 Operating business segments
    • 7.4.4 Product portfolio
    • 7.4.5 Business performance
    • 7.4.6 Key strategic moves and developments
  • 7.5 Croda International Plc
    • 7.5.1 Company overview
    • 7.5.2 Company snapshot
    • 7.5.3 Operating business segments
    • 7.5.4 Product portfolio
    • 7.5.5 Business performance
    • 7.5.6 Key strategic moves and developments
  • 7.6 STEARINERIE DUBOIS
    • 7.6.1 Company overview
    • 7.6.2 Company snapshot
    • 7.6.3 Operating business segments
    • 7.6.4 Product portfolio
    • 7.6.5 Business performance
    • 7.6.6 Key strategic moves and developments
  • 7.7 Gattefosse
    • 7.7.1 Company overview
    • 7.7.2 Company snapshot
    • 7.7.3 Operating business segments
    • 7.7.4 Product portfolio
    • 7.7.5 Business performance
    • 7.7.6 Key strategic moves and developments
  • 7.8 Tianshui Huayuan Pharmaceutical Equipment technology Co.,ltd
    • 7.8.1 Company overview
    • 7.8.2 Company snapshot
    • 7.8.3 Operating business segments
    • 7.8.4 Product portfolio
    • 7.8.5 Business performance
    • 7.8.6 Key strategic moves and developments